Late onset neutropenia during clozapine treatment

Psychiatry and Clinical Neurosciences

Volumn 55, Issue 5, 2001, Pages 547-548

  Tamam, Lut ^a,b   Kulan, Emel ^a   Ozpoyraz, Nurgul ^a  

^a CUKUROVA UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^b Doseme Mah Is Bankasi Koop Evleri   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; CLOZAPINE; DIAZEPINE DERIVATIVE; HALOPERIDOL; NEUROLEPTIC AGENT; PIMOZIDE;

ADULT; CASE REPORT; HEMATOLOGIC DISEASE; HUMAN; LETTER; LEUKOCYTE COUNT; MALE; NEUTROPENIA; ONSET AGE; PATIENT MONITORING; RISK BENEFIT ANALYSIS; SCHIZOPHRENIA;

ADULT; CLOZAPINE; HUMANS; LEUKOCYTE COUNT; MALE; NEUTROPENIA; NEUTROPHILS; SCHIZOPHRENIA, PARANOID;

EID: 0034795538     PISSN: 13231316     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1819.2001.904(1).x     Document Type: Letter

References (3)

1. Clozapine-induced agranulocytosis: Incidence and risk factors in the United States
2. Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland
3. Haematological side effects of clozapine: Patient characteristics